{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:06:43Z","timestamp":1789160803123,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, & Immunity - Health"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbih.2026.101312","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:11:22Z","timestamp":1784823082000},"page":"101312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Transdiagnostic determinants of Growth Differentiation Factor-15 (GDF-15) in psychiatric in-patients: age, renal indices, interleukin-6 (IL-6) and soluble urokinase plasminogen activator receptor (suPAR)"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2649-6732","authenticated-orcid":false,"given":"Evangelia Maria","family":"Tsapakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Keskilidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Karapatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theocharis","family":"Kyziridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prokopios","family":"Prokopiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Karalazou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Thisiadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kali","family":"Makedou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos N.","family":"Fountoulakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbih.2026.101312_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109130","article-title":"Interleukin-6 cytokine: an overview of the immune regulation, immune dysregulation, and therapeutic approach","volume":"111","author":"Aliyu","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbih.2026.101312_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2025.120303","article-title":"suPAR as a biomarker of support in different clinical settings","volume":"573","author":"Belvederi","year":"2025","journal-title":"Clinica chimica acta; international journal of clinical chemistry"},{"issue":"1","key":"10.1016\/j.bbih.2026.101312_bib3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1186\/s12888-021-03522-6","article-title":"Exploring low grade inflammation by soluble urokinase plasminogen activator receptor levels in schizophrenia: a sex-dependent association with depressive symptoms","volume":"21","author":"Bigseth","year":"2021","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.bbih.2026.101312_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.18553\/jmcp.2022.28.1.58","article-title":"Application of a diazepam milligram equivalency algorithm to assess benzodiazepine dose intensity in Rhode Island in 2018","volume":"28","author":"Borrelli","year":"2022","journal-title":"Journal of managed care & specialty pharmacy"},{"issue":"9","key":"10.1016\/j.bbih.2026.101312_bib5","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/s42255-025-01353-3","article-title":"Metabolic messenger: growth differentiation factor 15","volume":"7","author":"Breit","year":"2025","journal-title":"Nat. Metab."},{"issue":"1","key":"10.1016\/j.bbih.2026.101312_bib6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41398-022-02142-2","article-title":"Transdiagnostic inflammatory subgroups among psychiatric disorders and their relevance to role functioning: a nested case-control study of the ALSPAC cohort","volume":"12","author":"Byrne","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbih.2026.101312_bib7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1192\/bjp.2022.19","article-title":"Life expectancy and years of potential life lost in bipolar disorder: systematic review and meta-analysis","volume":"221","author":"Chan","year":"2022","journal-title":"Br. J. Psychiatr. : J. Ment. Sci."},{"key":"10.1016\/j.bbih.2026.101312_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2025.111446","article-title":"The effect of the number of psychiatric hospitalizations and diagnosis in serum levels of CCL11 and GDF15 in individuals with stable schizophrenia, bipolar disorder, and major depressive disorder: the compass between neuro and somatoprogression","volume":"141","author":"Costanzi","year":"2025","journal-title":"Progress in neuro-psychopharmacology & biological psychiatry"},{"key":"10.1016\/j.bbih.2026.101312_bib9","first-page":"1","article-title":"Growth differentiation factor 15 (GDF-15) in kidney diseases","volume":"114","author":"Delrue","year":"2023","journal-title":"Adv. Clin. Chem."},{"issue":"8","key":"10.1016\/j.bbih.2026.101312_bib10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S2215-0366(19)30132-4","article-title":"The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness","volume":"6","author":"Firth","year":"2019","journal-title":"The Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.bbih.2026.101312_bib11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1017\/S1092852924000026","article-title":"Somatic multicomorbidity and disability in patients with psychiatric disorders in comparison to the general population: a quasi-epidemiological investigation in 54,826 subjects from 40 countries (COMET-G study)","volume":"29","author":"Fountoulakis","year":"2024","journal-title":"CNS Spectr."},{"issue":"9","key":"10.1016\/j.bbih.2026.101312_bib12","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jacc.2022.06.017","article-title":"Severe Mental Illness and Cardiovascular\u00a0Disease","volume":"80","author":"Goldfarb","year":"2022","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1016\/j.bbih.2026.101312_bib13","first-page":"117","article-title":"Increased GDF-15 in chronic male patients with schizophrenia: correlation with body mass index and cognitive impairment","volume":"10","author":"Guo","year":"2024","journal-title":"Schizophrenia (Heidelberg, Germany)"},{"key":"10.1016\/j.bbih.2026.101312_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jad.2015.03.021","article-title":"Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials","volume":"180","author":"Hayasaka","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbih.2026.101312_bib15","article-title":"The energetic stress cytokine GDF15 is elevated in the context of chronic and acute psychosocial stress","author":"Huang","year":"2025","journal-title":"bioRxiv : the preprint server for biology"},{"issue":"3","key":"10.1016\/j.bbih.2026.101312_bib16","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12020-023-03377-9","article-title":"Growth differentiation factor 15 (GDF-15) in endocrinology","volume":"81","author":"Iglesias","year":"2023","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.bbih.2026.101312_bib17","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.1038\/s41598-017-07503-2","article-title":"Plasma GDF15 level is elevated in psychosis and inversely correlated with severity","volume":"7","author":"Kumar","year":"2017","journal-title":"Sci. Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.bbih.2026.101312_bib18","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","article-title":"Dose equivalents for antipsychotic drugs: the DDD method","volume":"42","author":"Leucht","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbih.2026.101312_bib19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbi.2021.08.224","article-title":"suPAR: a newer biomarker of systemic chronic inflammation","volume":"98","author":"Marsland","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbih.2026.101312_bib20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.bbi.2017.01.011","article-title":"The effects of acute psychological stress on circulating and stimulated inflammatory markers: a systematic review and meta-analysis","volume":"64","author":"Marsland","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbih.2026.101312_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2021.105200","article-title":"Immune-inflammatory markers and psychosis risk: a systematic review and meta-analysis","volume":"127","author":"Misiak","year":"2021","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbih.2026.101312_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2023.03.025","article-title":"Associations between plasma inflammatory markers and psychotic disorder, depressive disorder and generalised anxiety disorder in early adulthood: a nested case-control study","volume":"111","author":"Mongan","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbih.2026.101312_bib23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bbi.2024.06.003","article-title":"Associations between soluble urokinase plasminogen activator receptor (suPAR) concentration and psychiatric disorders - a systematic review and meta-analysis","volume":"120","author":"Murphy","year":"2024","journal-title":"Brain Behav. Immun."},{"issue":"3","key":"10.1016\/j.bbih.2026.101312_bib24","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/schbul\/sbu118","article-title":"Soluble urokinase-type plasminogen activator receptor levels in patients with schizophrenia","volume":"41","author":"Nielsen","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbih.2026.101312_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.780641","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) as a biomarker of systemic chronic inflammation","volume":"12","author":"Rasmussen","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbih.2026.101312_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96352-1","article-title":"Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit","volume":"11","author":"Reisinger","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbih.2026.101312_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1612703","article-title":"C-reactive protein: the nexus between inflammation and protein misfolding diseases","volume":"16","author":"Roy","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbih.2026.101312_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10522-024-10164-0","article-title":"GDF15\/MIC-1: a stress-induced immunosuppressive factor which promotes the aging process","volume":"26","author":"Salminen","year":"2024","journal-title":"Biogerontology"},{"issue":"6","key":"10.1016\/j.bbih.2026.101312_bib29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.tem.2024.09.002","article-title":"GDF15 is still a mystery hormone","volume":"36","author":"Sigvardsen","year":"2025","journal-title":"Trends Endocrinol. Metabol.: TEM (Trends Endocrinol. Metab.)"},{"issue":"4","key":"10.1016\/j.bbih.2026.101312_bib30","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s11357-021-00359-5","article-title":"Longitudinal course of GDF15 levels before acute hospitalization and death in the general population","volume":"43","author":"Tavenier","year":"2021","journal-title":"GeroScience"},{"key":"10.1016\/j.bbih.2026.101312_bib31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbi.2021.08.209","article-title":"Associations between childhood victimization, inflammatory biomarkers and psychotic phenomena in adolescence: a longitudinal cohort study","volume":"98","author":"Trotta","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.bbih.2026.101312_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.61373\/bm025r.0005","article-title":"Manic symptoms in schizophrenia spectrum disorders","volume":"1","author":"Tsapakis","year":"2025","journal-title":"Brain Medicine"},{"issue":"1","key":"10.1016\/j.bbih.2026.101312_bib33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41398-019-0570-y","article-title":"Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses","volume":"9","author":"Yuan","year":"2019","journal-title":"Transl. Psychiatry"}],"container-title":["Brain, Behavior, & Immunity - Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354626001456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666354626001456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:16:25Z","timestamp":1789157785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666354626001456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"alternative-id":["S2666354626001456"],"URL":"https:\/\/doi.org\/10.1016\/j.bbih.2026.101312","relation":{},"ISSN":["2666-3546"],"issn-type":[{"value":"2666-3546","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transdiagnostic determinants of Growth Differentiation Factor-15 (GDF-15) in psychiatric in-patients: age, renal indices, interleukin-6 (IL-6) and soluble urokinase plasminogen activator receptor (suPAR)","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, & Immunity - Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbih.2026.101312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101312"}}